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We conducted a molecular analysis of Francisella tular-
ensis strains isolated in Switzerland and identiﬁ  ed a speciﬁ  c 
subpopulation belonging to a cluster of F. tularensis subsp. 
holarctica that is widely dispersed in central and western 
continental Europe. This subpopulation was present before 
the tularemia epidemics on the Iberian Peninsula.
T
ularemia is a classical zoonosis caused by the faculta-
tive intracellular bacterium Francisella tularensis; it 
is transmissible to humans at infectious doses as low as 
10–50 bacteria when inhaled in aerosols or by inoculation 
of the skin. Traditionally, tularemia is thought of as a dis-
ease contracted by persons performing outdoor activities 
such as hunting or farming, but it can also be acquired 
from pets, for example, hamsters or prairie dogs, which 
are occasionally traded internationally (1). During the 
past 15 years, the reemergence of tularemia has been re-
ported in several European countries (2–4). Spain is a no-
table example, reporting 916 human infections from 1997 
through 2007 in the Castilla and León regions alone (5). 
However, tularemia is rarely diagnosed in central Europe. 
In Switzerland, F. tularensis infection was ﬁ  rst described 
in the 1950s, but the pathogen was not isolated until 1996, 
when F. tularensis infection began to reappear sporadi-
cally. To better understand the genetic diversity of Swiss 
F. tularensis strains and their relationship to strains from 
other geographic areas, we analyzed strains from Switzer-
land by using several methods that had been previously 
demonstrated to resolve genetic differences between F. 
tularensis subsp. holarctica strains: multilocus tandem 
repeat analysis (MLVA), canonical F. tularensis insertion 
deletion element (Ftind) analysis, and region of difference 
(RD) 23 analysis (3,6,7).
The Study
Thirteen F. tularensis isolates collected over the past 
10 years in Switzerland (Figure 1) were subjected to ex-
tensive genetic characterization. The species and subspe-
cies designations of all strains were conﬁ  rmed by real-time 
PCR that targeted the fopA gene and by ampliﬁ  cation of the 
RD1 region (8), which showed that all strains were F. tula-
rensis subsp. holarctica. A reference panel of 12 F. tular-
ensis subsp. holarctica strains (7) and the genome sequence 
of the strain isolated in France, FTNF002 (GenBank acces-
sion no. NC_009749), were included in the study to rep-
resent the currently known genetic subpopulations within 
the subspecies. All strains from Switzerland were geneti-
cally characterized at 6 highly variable loci (by MLVA) 
and 14 more stable loci that indicate the classiﬁ  cation F. 
tularensis subsp. holarctica strains into genetic subpopula-
tions (by Ftind analysis) (3,6,7). The RD analysis was also 
performed because a 1.59-kb deletion marker, RD23, was 
reported to be restricted to strains from France and Spain 
(3). The MLVA markers (M3, M6, M20, M21, M22, and 
M24) and Ftind markers (Ftind 25–38) were ampliﬁ  ed by 
PCR and then sequenced with an ABI Prism 3100 genet-
ic analyzer (Applied Biosystems, Foster City, CA, USA) 
and the BigDye Terminator cycle sequencing kit (Applied 
Biosystems). DNA fragment sizes were calculated from 
the nucleotide sequences of the MLVA and Ftind markers 
and used to compare the isolates with previously analyzed 
strains from the United States, Japan, France, and Russia 
(3,7). The RD23 marker was assayed by using standard 
PCR and agarose gel methods as previously described (3). 
A cluster analysis based on the MLVA and indel size data 
was performed by using BioNumerics version 3.5 (Applied 
Maths, Kortrjik, Belgium).
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FSC035 Beaver, 1976, USA
FSC012 Tick, 1941, USA
FSC519 Human, 2004, Sweden
JF3829 Zoo monkey, 2002, Switzerland
JF3826 Zoo monkey, 1996, Switzerland
JF3828 Human, 2004, Switzerland
JF4092 Wild hare, 2007, Switzerland
JF3825 Zoo monkey, 2006, Switzerland
JF3821 Wild hare, 1997, Switzerland
JF3820 Wild hare, 1998, Switzerland
JF3859 Wild hare, 1998, Switzerland
JF3822 Wild hare, 1998, Switzerland
JF3824 Human, 2005, Switzerland
FSC257 Tick, 1949, Russia
FSC171 Human, 1995, Sweden
FSC398 Human, 2003, Sweden
FSC412 Human, 2003, Sweden
FSC429 Human, 2003, Sweden
FSC017 Human, 1926, Japan
FSC021 Human, 1958, Japan
FSC022 Human, 1950, Japan
Central and 
Western 
European 
cluster
JF4241 Wild hare, 2008, Switzerland
JF4212 Human, 2008, Switzerland
JF4128 Human, 2008, Switzerland
FTNF002 Human, 2000, France
LVS Vole, unknown, Russia
Figure 1. Genetic relationships between Francisella tularensis 
subsp.  holarctica strains isolated in Switzerland and strains of 
wider geographic origin. The unweighted pair group method with 
arithmetic mean phylogram is based on the combined Ftind and 
multiple-locus variable-number tandem repeat analysis. Bootstrap 
values >80% are given at the respective nodes and were calculated 
by using 10,000 iterations. Scale bar indicates genetic distance.As expected, the indel markers served to place each 
strain into major branches of the cluster tree, and the more 
variable MLVA markers provided the ﬁ  ne resolution at the 
tips of the tree. The Switzerland strains belonged to the 
same genetic cluster as the F. tularensis strain FTNF002 
from France (Figure 1) that in a previous work clustered 
with strains from Spain (3,9). Moreover, all the Swiss 
strains exhibited the 1.59-kb genomic deletion at the RD23 
locus and the unique 464-bp size at MLVA marker M24, 
which conﬁ   rmed their close relationship to the French 
strain FTNF002 as well as to other strains from France and 
Spain (3).
The ﬁ  nding of F. tularensis strains in Switzerland rep-
resent sporadic occurrences of tularemia without any obvi-
ous epidemiologic connection. The strains originated from 
6 hares, 3 monkeys, and 4 persons and were collected at 
different locations in Switzerland over a period of 10 years 
(Figure 2). The human infections most likely occurred 
through direct contact with wild animals, through rodent 
bites, and through consumption of a hare cooked at low 
temperature. Those isolates could be resolved into 7 dif-
ferent genotypes (Figure 2). Four Swiss strains displayed a 
genetic proﬁ  le identical to that of the representative French 
strain FTNF002 (3). The other 6 genotypes were closely 
related to FTNF002, and all corresponded to the subclade 
B.Br:FTNF002–00 as deﬁ  ned by canonical single nucle-
otide polymorphisms  by Vogler et al. (9). This cluster, 
which also contained the strains from the Iberian Penin-
sula, seems to have spread throughout central and western 
Europe. Moreover, all the Swiss strains were susceptible 
to erythromycin (MICs 0.25 μg/mL to 1 μg/mL), which is 
a phenotypic marker that has previously been suggested to 
divide F. tularensis subsp. holarctica strains into 2 taxo-
nomic groups (10–12).
Conclusions
Strains of F. tularensis from Switzerland (central Eu-
rope) genetically clustered with strains from France and 
Spain (western Europe) as determined by the unique 464-
bp genetic marker M24 and a speciﬁ  c deletion at marker 
RD23. Furthermore, strains within the cluster differed at 
only 2 MLVA markers,and 4 other MLVA and 14 Ftind 
markers were identical. In a previous study that included 
strains from the 1997–1998 tularemia outbreak in Spain, 
the speciﬁ  c M24 allele and the RD23 deletion were found 
in 49 of 49 strains from Spain and France but in only 1 of 
189 strains from 7 northern and eastern European coun-
tries and Japan (3). The tularemia outbreak of 1997–1998 
in Spain, which resulted in >500 human cases (5), was 
thus caused by F. tularensis strains that were genetically 
closely related to strains recovered in Switzerland from 
1996 onwards, before the beginning of the outbreaks in 
Spain. This genetic relationship shows that factors other 
than the presence or introduction of a speciﬁ  c clone of 
the infectious agent per se determined the magnitude of 
the tularemia outbreaks in Spain. For epidemiologists to 
understand the distribution of F. tularensis (and other 
rare disease agents) in the environment and their propaga-
tion across national and geographic borders, surveillance 
programs that include molecular analyses of these agents 
should be undertaken in multiple countries, and the result-
ing data should be shared internationally.
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